RdRP-IN-7 is a RNA-dependent RNA polymerase (RdRp) inhibitor that shows the inhibition of SARS-CoV-2 infection with an IC50 of 8.2 µM, an IC90 of 14.1 µM and an CC90 of 79.1 µM. RdRP-IN-7 can be used for antiviral research[1].
Molecular Weight:
559.85
Formula:
C26H45N7O3Si2
Target:
SARS-CoV
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
